Oxcarbazepine versus phenytoin monotherapy for epilepsy

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 5, 2013, Pages

  Nolan, Sarah J ^a   Muller, Martie ^b   Tudur Smith, Catrin ^a   Marson, Anthony G ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

OXCARBAZEPINE; PHENYTOIN; ANTICONVULSIVE AGENT; CARBAMAZEPINE; DRUG DERIVATIVE;

ADOLESCENT; ADULT; AGED; COMPARATIVE EFFECTIVENESS; DRUG SAFETY; EVIDENCE BASED MEDICINE; FEMALE; GRAND MAL EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; REVIEW; SYSTEMATIC REVIEW; TREATMENT WITHDRAWAL; ANALOGS AND DERIVATIVES; EPILEPSIES, PARTIAL; EPILEPSY; INDUCTION CHEMOTHERAPY; META ANALYSIS; FOCAL EPILEPSY;

ANTICONVULSANTS; CARBAMAZEPINE; EPILEPSIES, PARTIAL; EPILEPSY; HUMANS; INDUCTION CHEMOTHERAPY; PHENYTOIN; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84891702084     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003615.pub3     Document Type: Review

References (38)

1. Aikia M, Kalviainen R, Sivenius J, Halonen T, Riekkinen PJ. Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up. Epilepsy Research 1992;11(3):199-203.
2. Bill PA, Vigonius U, Pohlmann H, Guerreiro CAM, Kochen S, Saffer D, et al.A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy. Epilepsy Research 1997;27(3):195-204.
3. Guerreiro MM, Vigonius U, Pohlmann H, De Manreza ML, Fejerman N, Antoniuk SA, et al.A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Research 1997;27(2):205-13.
4. D'Souza J, Miller M, Sturm YE. Oxcarbazepine is at least as effective and well-tolerated as phenytoin with a superior safety profile over long-term treatment in patients with partial seizures. Epilepsia 2003;44 Suppl 9:265.
5. Guerreiro M. Better seizure control and tolerability over the long term with oxcarbazepine (Trileptal (R)) monotherapy compared with phenytoin in newly diagnosed children and adolescents with partial and generalised tonic-clonic seizures. Epilepsia 2003;44 Suppl 8:148-9.
6. Sabers A, Maller A, Dam M, Smed A, Arlien-Saborg P, Buchman J, et al.Cognitive function and anticonvulsant therapy: effect of monotherapy in epilepsy. Acta Neurologica Scandinavica 1995;92(1):19-27.
7. Schmidt D. How reliable is early treatment response in predicting long-term seizure outcome?. Epilepsy & Behavior 2007;10(4):588-94.
8. Sturm YE, Miller M. Long-term oxcarbazepine therapy in children is at least as effective as and better tolerated than phenytoin. Epilepsia 2003;44 Suppl 9:272.
9. Bang L, Goa K. Oxcarbazepine: a review of its use in children with epilepsy. Paediatric Drugs 2003;5(8):557-73.
10. Beydoun A, Sachdeo RC, Rosenfeld WE, Krauss GL, Sessler N, Mesenbrink P, et al.Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial. Neurology 2000;54(12):2245-51.
11. Carl GF, Smith ML. Phenytoin-folate interactions: differing effects of the sodium salt and the free acid of phenytoin. Epilepsia 1992;33(2):372-5.
12. Castillo S, Schmidt DB, White S. Oxcarbazepine add-on for drug-resistant partial epilepsy. Cochrane Database of Systematic Reviews 2000, Issue 3. [DOI: 10.1002/14651858.CD002028].
13. Christe W, Krämer G, Vigonius U, Pohlmann H, Steinhoff BJ, Brodie MJ, et al.A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. Epilepsy Research 1997;26(3):451-60.
14. Cockerell OC, Johnson AL, Sander JW, Hart YM, Shorvon SD. Remission of epilepsy: results from the National General Practice Study of Epilepsy. Lancet 1995;346(8968):140-4.
15. Dam M, Ekberg R, Loyning Y, Waltimo O, Jakobsen K. A double blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. Epilepsy Research 1989;3(1):70-6.
16. Gladstone DJ, Bologa M, Maguire C, Pastuszak A, Koren G. Course of pregnancy and fetal outcome following maternal exposure to carbamazepine and phenytoin: a prospective study. Reproductive Toxicology 1992;6(3):257-61.
17. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]; Appendix 5b. www.cochrane.org/resources/handbook/hbook.htm (accessed 19 December 2005).
18. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22(4):489-501.
19. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30(4):389-99.
20. Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, Guerreiro C, et al.ILAE treatment guidelines: evidence based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006;47(7):1094-120.
21. Kwan P, Brodie MJ. Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy. Neurology 2003;60(11 Suppl 4):S2-12.
22. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
23. Malfosse A, Genton P, Hirsch E, Marescaux C, Broglin D, Bernasconi R. Idiopathic Generalised Epilepsies: Clinical, Experimental and Genetic. Eastleigh: John Libbey and Company, 1994.
24. Mattson RH, Cramer JA, Collins JF, Smith DB, Delgado-Escueta AV, Browne TR, et al.Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. New England Journal of Medicine 1985;313(3):145-51.
25. Meador K, Reynolds MW, Crean S, Fahrbach K, Probst C. Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts. Epilepsy Research 2008;81(1):1-13.
26. Nulman I, Scolnik D, Chitayat D, Farkas LD, Koren G. Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications. American Journal of Medical Genetics 1997;68(1):18-24.
27. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
28. Pohlmann H. Personal communication 23 September 2005.
29. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
30. Schachter SC, Vazquez B, Fisher RS, Laxer KD, Montouris GD, Combs-Cantrell DT, et al.Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures. Neurology 1999;52(4):732-7.
31. Scheinfeld N. Phenytoin in cutaneous medicine: its uses, mechanisms and side effects. Dermatology Online Journal 2003;9(3):6.
32. StataCorp. Stata Statistical Software: Release 11. College Station, TX: StataCorp LP, 2009.
33. Tennis P, Stern RS. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study. Neurology 1997;49(2):542-6.
34. Wallace H, Shorvon SD, Hopkins A, O'Donoghue M. Guidelines for the clinical management of adults with poorly controlled epilepsy. National Society of Epilepsy guidelines. London: Royal College of Physicians, 1997.
35. Wellington K, Goa KL. Oxcarbazepine: an update of its efficacy in the management of epilepsy. CNS Drugs 2001;15(2):137-63.
36. Wilder BJ. Phenytoin: clinical use. Antiepileptic Drugs. 4th Edition. New York: Raven Press, 1995:339-44.
37. Williamson PR, Tudur Smith C, Hutton JL, Marson AG. Aggregate data meta-analysis with time-to-event outcomes. Statistics in Medicine 2002;21(22):3337-51.
38. Muller M, Marson AG, Williamson PR. Oxcarbazepine versus phenytoin monotherapy for epilepsy. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD003615.pub2].